GRS and CONUSBAT team up to offer guidance on EU cosmetics regulation
The two organisations have joined forces to provide guidance on the new cosmetic product regulation; EU Regulation 1223/2009.
GRS states that its strategic collaboration with CONUSBAT will ensure that manufacturers of cosmetics products comply with the new requirements before placing their products on the EU market.
Clearer definitions
This will include providing clearer definitions on herbal products which are often borderline between cosmetic and medicines, an area which GRS specialises in.
"Regulations are regularly reviewed and are becoming increasingly stringent. This is currently happening with cosmetics following the cessation of the current EU Cosmetic Directive which is to become the EU Cosmetic Products Regulation, enforceable from next July,” said GRS director Greer Deal.
GRS anticipates that many European companies, as well as non-European companies wanting to trade within the EU, will need help and guidance with the new requirements, and this drove the collaboration.
A good match
"It was important for us to find the right consultancy specializing in cosmetic regulations who share the same values as GRS and, in CONUSBAT, we are confident that we have found our ideal strategic partner who can assist our cosmetic clients through the coming regulatory changes,” added Deal.
Steven L. Hanft, founder and president of CONUSBAT, also expressed his pleasure in teaming up with the British consultancy as a regulatory partner.
“Their expertise with traditional medicinal and herbal products complements the work of CONUSBAT and the support we provide to our global clients on compliance for EU REACH legislation, cosmetic safety assessment and EU regulations for cosmetics, consumer health care, household products and fine chemicals.”
"As GRS are specialists in borderline products, our capabilities will be enhanced in advising clients about the new Cosmetic Products Regulation, alongside the expertise of Dr Annelie Struessmann, CONUSBAT's Technical and Regulatory Director,” he said.
